Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Impax Laboratories Inc : Impax Laboratories to Present at the Goldman Sachs Annual Global Healthcare Conference

06/04/2012| 09:35am US/Eastern
Recommend:
0

Impax Laboratories, Inc. (NASDAQ:IPXL) today announced that the Company will present at the Goldman Sachs 33rd Annual Global Healthcare Conference on Thursday, June 7, at 10:00 a.m. PT. The conference will be held at the Terranea in Rancho Palos Verdes, California.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Impax Laboratories, Inc.
Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
215-558-4526
www.impaxlabs.com


© Business Wire 2012
Recommend :
0
Partner Area
React to this article
 
Latest news on IMPAX LABORATORIES INC
2d ago IMPAX LABORATORIES INC: Impax Laboratories Launches Authorized Generic of Zomig..
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/10 IMPAX LABORATORIES INC: Impax Laboratories to Present at the Bank of America Me..
05/02 IMPAX LABORATORIES INC: IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hour..
05/01 IMPAX LABORATORIES INC: Impax Laboratories Reports First Quarter 2013 Results
04/29DJGSK, Impax End Collaboration on IPX066 Parkinson's Treatment
04/29 IMPAX LABORATORIES INC: Impax Pharmaceuticals and GlaxoSmithKline Terminate The..
04/23 IMPAX LABORATORIES INC: UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors ..
04/16 IMPAX LABORATORIES INC: SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors ..
04/16 IMPAX LABORATORIES INC: Amarin, Pharmacyclics, Anthera Pharma, Star Scientific,..
Advertisement
Chart
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
Impax Laboratories Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.